Miho Sasamata

Astellas Pharma (Japan)

Papers

1

Total Citations

22

H-Index

1

About

Dr. Miho Sasamata is a pioneering researcher at the intersection of stem cell biology and laboratory automation, whose work is redefining the scalability and reproducibility of induced pluripotent stem cell (iPSC) research. Her key contributions center on developing robust, automated platforms to overcome the technical bottlenecks that have long hindered iPSC applications in drug discovery. In her landmark 2021 study, Sasamata established a comprehensive protocol for using the Maholo LabDroid—a fully automated robotic system—to perform the complex, high-skill tasks of iPSC maintenance and differentiation. This work, which has garnered 22 citations, demonstrated that automation can reliably produce high-quality, consistent cell cultures, dramatically reducing the human error and expertise required. By creating a "robust platform" for iPSC research, Sasamata’s contributions are paving the way for high-throughput screening and more reproducible preclinical studies. Her achievements represent a critical step toward translating the promise of iPSCs into practical, scalable tools for early-stage drug discovery, making her a leading voice in the drive to merge advanced robotics with regenerative medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
22
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Establishment of a Robust Platform for Induced Pluripotent Stem Cell Research Using Maholo LabDroid
22 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Astellas Pharma (Japan)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago